Read + Share
Amedeo Smart
Independent Medical Education
Gross ND, Seiwert TY. Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard-of-care? Cancer 2024 Jan 18. doi: 10.1002/cncr.35198.PMID: 38236709
Email
LinkedIn
Facebook
Twitter
Privacy Policy